1. Professor association of herbal formula of Koreamedicine. Herbal formula. Seoul:Youngrimsa.2003:409.

2. Western Pacific region of the World HealthOrganization. WHO international standardterminologies on traditional medicine in thewestern pacific region. World HealthOrganization. 2007:186.

3. Sakamoto S, Yoshino H, Shirahata Y, Shimodairo K, Okamoto R. Pharmacotherapeutic effects ofKuei-chih-fu-ling-wan (Keishi-bukuryo-gan) onhuman uterine myomas. Am J Chin Med. 1992;20:313.

4. Cho JH. A pilot study of the difference betweenGyejibongnyeong-hwan and Gyejibongnyeong-hwan combined acupuncture therapy on the primary dysmenorrheal. J Orient Obstet. 2007;20(1):161-8.

5. Choi G, Cho J, Jang J, Lee K. Clinical study onthe efficacy of Gyejibongnyeong-hwan in thetreatment of menorrhalgia. J Orient ObstetGynecol. 2004;17(1):178-86.

6. Zhang WJ, Wang ZN, Zheng H, Zheng PE, MaBF, Zhuo LD. The role of Guizhifulingwan onangiogenesis of endometriosis model rat. J JinanUniv, Nat Sci Med Ed. 2004;25(2):164-74.

7. Liu HZ, Qiao FY, Chen SH, Lin XZ, Wang XR.Effects of Guizhifuling extracture on immunefunction in experimental rats with endometriosis.Herald of Medicine. 2005;124(17):566-8.

8. Cai XT, Hu CP, Hu TT, Wang ZG, Cao P, WangM. Effects of Guizhi Fuling capsule on theexpression of MCP-1 and ICAM-1 mRNA ofectopic endometrium in rats with endometriotics.Chin J Exp Tradit Med Formulae.2011;17(15):202-5.

9. Hu CP, Hu TT, Cai XT, Wang ZG, Lu WG, WanGP, at al. Effects of Guizhi Fuling capsule onquantity of CD4+ T lymphocytes and cytotoxicactivity of NK cells in spleen of rats withendometriotics. Chin J Exp Tradit MedFormulae. 2011;17(9):145-8.

10. Ji X, Gao J, Cai X, Lu W, Hu C, Wang, Z, etal. Immunological regulation of Chinese herbGuizhi Fuling Capsule on rat endometriosismodel. J Ethnopharmacol. 2011;134:624-9.

11. Ling HY. Mechanism research on treatment ofGuizhi Fuling pills for endometriosis in rats.Chin J Exp Tradit Med Formulae.2012;18(23):270-3.

12. Li L, Cheng GL, Gu FL, Wang YS. Preventiveand cure effects of guizhi fuling Pellet on rathysteromyoma models. Chin J Clin PharmacolTher. 2005;10(7):832-5.

13. Liu C, Fu YQ, Wang Y, Wang H, Liu WJ, WangZH, et al. Effects of Guizhi Fuling pill and betaken apart on warming yang and diureticpromoting blood circulation and removing bloodstasis in model of mice with hysteromyoma.Journal of Liaoning University of TCM.2009;11(11):214-6.

14. Mori T, Sakamoto S, Singtripop T, Park MK,Kato T, Kawashima S, et al. Suppression ofspontaneous development of uterineadenomyosis by a Chinese herbal medicine,Keishi-Bukuryo-Gan, in mice. Planta Med.1993;59:308-11.

15. Yao Z, Shulan Z. Inhibition effect ofGuizhi-Fuling-decoction on the invasion ofhuman cervical cancer. J Ethnopharmacol.2008;120:25-35.

16. Shi W, Liu RF, Yang XN, Xu L. Effect of GuizhiFuling capsule on the inflammatory cytokines inuterine tissue of the female rats withexperimental pelvic inflammatory disease.Journal of Nanjing University of TCM.2012;28(6):558-60.

17. Jiang SH, Liu WG, Yang LP, Wang L, WangXP, Wang DD. Therapeutic experimental studyof Guizhifuling Capsule on hyperplasia ofmammary glands in rats. Chinese TraditionalPatent Medicine. 2004;26(12):1040-2.

18. Liu HC, Liu WG, Yang LP. Effect of guizhifuling capsule on the endocrine and immunefunction in rats with hyperplasia of mammaryglands. Chin J Clin Rehabil. 2005;9(2):194-5.

19. Zhu XX, Zhang ZH, Qiu ZJ, Jia MC.Experimental study of Guizhi Fuling capsule oncyclomastopathy rats. Modern Journal ofIntegrated Traditional Chinese and WesternMedicine. 2006;15(5):571-6.

20. Giudice LC. Endometriosis. N Engl J Med.2010;362:2389-98.

21. Demirturk F, Aytan H, Caliskan AC, Aytan P,Koseoglu DR. Effect of peroxisome proliferatorActivated receptor-γ agonist rosiglitazone onthe induction of endometriosis in an experimentalrat model. J Soc Gynecol Investig. 2006;13(1):5862.

22. Machado DE, Berardo PT, Palmero CY,Nasciutti LE. Higher expression of vascular endothelialgrowth factor (VEGF) and its receptorVEGFR-2 (Flk-1) and metalloproteinase-9(MMP-9) in a rat model of peritoneal endometriosisis similar to cancer diseases. J Exp & ClinCancer Res. 2010;29(4):1-9.

23. He H, Ma XD. Expression and significance ofMMP-2, MMP-9 and VEGF in endometriosis.Progress in Modern Biomedicine.2009;9(21):4083-5.

24. Katayama H, Katayama T, Uematsu K, HiratsukaM, Kiyomura M, Shimizu Y, et al. Effect ofdienogest administration on angiogenesis andhemodynamics in a rat endometrial autograftmodel. Hum Reprod. 2010;25(11):2851-8.

25. Kim JH, Yang YI, Ahn JH, Lee JG, Lee KT,Choi JH. Deer (Cervus elaphus) antler extractsuppresses adhesion and migration ofendometriotic cells and regulates MMP-2 andMMP-9 expression. J Ethnopharmacol.2012;140:391-7.

26. Malvezzi H, Aguiar VG, de Paz CCP,Tanus-Santos JE, de Araujo Penna IA, NavarroPA. Increased circulating MMP-2 levels ininfertile patients with moderate and severe pelvicendometriosis. Reprod Sci. 2012;20(5):557-62.

27. Bendrik C, Karlsson L, Dabrosin C. Increasedendostatin generation and decreased angiogenesisvia MMP-9 by tamoxifen in hormone dependentovarian cancer. Cancer Lett. 2010;292:32-40.

28. Koyama N, Matsuura K, Okamura H. Cytokinesin the peritoneal fluid of patients withendometriosis. Int J Gynecol Obstet. 1993;43:4550.

29. Tao Y, Zhang Q, Huang W, Zhu H, Zhang D,Luo W. The peritoneal leptin, MCP-1 and TNF-ain the pathogenesis of endometriosis-associatedinfertility. Am J Reprod Immunol. 2011;65:4036.

30. Tran LVP, Tokushige N, Berbic M, Markham R,Fraser IS. Macrophages and nerve fibres inperitoneal endometriosis. Hum Reprod.2009;24(4):835-41.

31. Vigano P, Pardi R, Magri B, Busacca M, DiBlasio AM, Vignali M. Expression ofintercellular adhesion molecule-1 (ICAM-1) oncultured human endometrial stromal cells and itsrole in the interaction with natural killers. AmJ Reprod Immunol. 1994;32:139-45.

32. Vigano P, Infantino M, Lattuada D, Lauletta R,Ponti E, Somigliana E, et al. Intercellularadhesion molecule-1 (ICAM-1) genepolymorphisms in endometriosis. Mol HumReprod. 2003;9:47-52.

33. Wu MH, Yang BC, Lee YC, Wu PL, Hsu CC.The differential expression of intercellularadhesion molecule-1 (ICAM-1) and regulationby interferon-gamma during the pathogenesis ofendometriosis. Am J Reprod Immunol.2004;51:373-80.

34. Berbic M, Fraser IS. Regulatory T cells and otherleukocytes in the pathogenesis of endometriosis.J Reprod Immunol. 2011;88:149-55.

35. Itoh H, Uchida M, Sashihara T, Ji ZS, Li J, TangQ, et al. Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study. Cytotechnology. 2011;63(2):153-61.

36. Tanaka E, Sendo F, Kawagoe S, Hiroi M.Decreased natural killer cell activity in womenwith endometriosis. Gynecol Obstet Invest.1992;34:27-30.

37. Ewington L, Taylor A, Sriraksa R, Horimoto Y,Lam EWF, El-Bahrawy MA. The expression ofinterleukin-8 and interleukin-8 receptors in endometrial carcinoma. Cytokine. 2012;59(2):417-22.

38. Ohata Y, Harada T, Miyakoda H, Taniguchi F,Iwabe T, Terakawa N. Serum interleukin-8 levelsare elevated in patients with ovarianendometrioma. Fertil Steril. 2008;90(4):994-9.

39. Altan ZM, Denis D, Kagan D, Grund EM,Palmer SS, Nataraja SG. A long-acting tumornecrosis factor α-binding protein demonstratesactivity in both in vitro and in vivo models ofendometriosis. J Pharmacol Exp Therapeut.2010;334:460-6.

40. Braundmeier AG, Nowak RA. Cytokinesregulate matrix metalloproteinases in humanuterine endometrial fibroblast cells through amechanism that does not involve increases inextracellular matrix metalloproteinase inducer.Am J Reprod Immunol. 2006;56:201-14.

41. Li Z, Sun Y, Min W, Zhang D. Correlationbetween overexpression of transforming growthfactor-beta 1 in occluded fallopian tubes andpostsurgical pregnancy among infertile women.Int J Gynecol Obstet. 2011;112:11-4.

42. Berkkanoglu M, Arici A. Immunology andEndometriosis. Am J Reprod Immunol.2003;50:48-59.

43. Gajbhiye R, Suryawanshi A, Khan S, Meherji P,Warty N, Raut V, et al. Multiple endometrialantigens are targeted in autoimmuneendometriosis. Reprod Biomed Online.2008;16(6):817-24.

44. Huang SH. Correlative study betweenendometriosis and immune infertility. ModDiagn Treat. 2011;22(1):7-11.

45. Kyama CM, Debrock S, Mwenda JM, D’HoogheTM. Potential involvement of the immune systemin the development of endometriosis. ReprodBiol Endocrinol. 2003;1:123.

46. Chatenoud L, Salomon B, Bluestone JA.Suppressor T cells they’re back and critical forregulation of autoimmunity. Immunol Rev. 2001;182:149-63.

47. Szyllo K, Tchorzewski H, Banasik M, GlowackaE, Lewkowicz P, Kamer-Bartosinska A. Theinvolvement of T lymphocytes in thepathogenesis of endometriotic tissues overgrowthin women with endometriosis. MediatorsInflamm. 2003;12(3):131-8.

48. Yang JB, Yang F. Effect of QuYiKang on TXB2and 6-Keto-PGF1α of endometriosis in rats.Chinese Archives of Traditional ChineseMedicine. 2010;28(9):1881-3.

49. Enzler M, Schipp S, Nicolas LB, Dingemanse J,Siethoff C. Determination of 6-ketoprostaglandin F1α and its metabolites in humanplasma by LC MS/MS. J Chromatogr B.2012;901(15):67-71.

50. He K, Liu J, Li CX, Liu LH, Li Q. The Effectof Dan'e Fukang decocted extract on TXB2 and6-keto-PGF1α of endometriosis rats. Drugs andClinic. 2012;9(17):30-3.

51. Paolo V, Paola S, Alberto P, Barbara M, LucaB, Giorgio PC. Mononuclear cell[beta]-endorphin concentration in women withand without endometriosis. Obstetrics &Gynecology. 1992;79(5):743-6.

52. Rasmussen NA, Farr LA. Beta-endorphinresponse to an acute pain stimulus. J NeurosciMethods. 2009;177:285-8.

53. Saadawi S, Jalil J, Jasamai M, Jantan I. Inhibitoryeffects of acetylmelodorinol, chrysin andpolycarpol from Mitrella kentii on prostaglandinE2 and thromboxane B2 production and plateletactivating factor receptor binding. Molecules.2012;17:4824-35.

54. Osada H, Silber S, Kakinuma T, Nagaishi M,Kato K, Kato O. Surgical procedure to conservethe uterus for future pregnancy in patientssuffering from massive adenomyosis. ReprodBiomed Online. 2011;22(1):94-9.

55. Sakamoto S, Mori T, Singtripop T, KawashimaS, Suzuki S, Kudo H, et al. Increase of DNAsynthesis in uterine adenomyosis in mice withectopic pituitary isograft. Acta Anatomica.1992;145:162-6.

56. Zhou YF, Mori T, Kudo H, Asakai R, Sassa S,Sakamoto S. Effects of angiogenesis inhibitorTNP-470 on the development of uterineadenomyosis in mice. Fertil Steril.2003;80(Supplement 2):788-94.

57. Shintani M, Urano M, Takakuwa Y, Kuroda M,Kamoshida S. Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidinekinase-1 and thymidylate synthase, in various types of cancer. Oncol Rep. 2010;23(5):1345-50.

58. Lee KH, Hur HS, Im SA, Lee J, Kim HP, YoonYK, et al. RAD001 shows activity against gastriccancer cells and overcomes 5-FU resistance bydownregulating thymidylate synthase. CancerLett. 2010;299:22-8.

59. The treatment of gynecological diseases. 2013;[1screen]. Available at:URL:http://www.medicaltravel.ru/en/index.php?categoryid=20. Assessed Apr 10, 2013.

60. Gu M, Liu GJ, Wang YF, Wang J. Experimentalstudy of the effect Fengwangjiang onhysteromyoma in rat models. Journal ofHangzhou Teachers College (Medicine Edition).2007;27(3):141-2.

61. Hu SQ, Zheng HB, Wang XH. Effect of letrozoleon the secretion of estradiol by hysteromyomacells in vitro. Herald of Medicine.2005;24(12):1101-3.

62. Yin H. Effect of testosterone undecanoatecombined with Gongliuqing on hysteromyoma ofpremenopause. Journal of Xinxiang MedicineCollege. 2011;28(4):506-8.

63. Kleinberg DL, Ameri P, Singh B. Pasireotide, anIGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.Pituitary. 2011;14(1):44-52.

64. Bocchinfuso WP, Hively WP, Couse JF, VarmusHE, Kor KS. A mouse mammary tumorVirus-Wnt-1 transgene induces mammary glandhyperplasia and tumorigenesis in mice lackingestrogen receptor-α. Cancer Res. 1999;59:1869-76.

65. Milliken EL, Ameduri RK, Landis MD, BehroozA, Abdul-Karim FW, Keri RA. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice.Endocrinology. 2002;143(9):3671-80.

66. Harvell DME, Strecker TE, Tochacek M, Xie B,Pennington KL, McComb RD, et al. Ratstrain-specific actions of 17β-estradiol in themammary gland: Correlation betweenestrogen-induced lobuloalveolar hyperplasia andsusceptibility to estrogen-induced mammarycancers. PNAS. 2000;97(6):2779-84.

67. Sirotkovic-Skerlev M, Cacev T, Krizanac S,Kuli? A, Pavelic K, Kapitanovic S. TNF alphapromoter polymorphisms analysis in benign andmalignant breast lesions. Exp Mol Pathol.2007;83(1):54-8.

68. Kamali-Sarvestania E, Merat A, Talei AR.Polymorphism in the genes of alpha and betatumor necrosis factors (TNF-α and TNF-β) andgamma interferon (IFN-γ) among Iranian womenwith breast cancer. Cancer Lett. 2005;223:1139.

69. Garcia-Tunon I, Ricote M, Ruiz A, Fraile B,Paniagua R, Royuela M. Interleukin-2 and itsreceptor complex (α, β and γ chains) in in situand infiltrative human breast cancer: animmunohistochemical comparative study. BreastCancer Res. 2004;6:R1-R7.

70. Zhang W, Liu J, Guo X, Chen F. The effectsof acupuncture on serum IL- 2 and TNF- A ofrats with experimental mammary glandhyperplasia (MGH). Journal of Shaanxi Collegeof TCM. 2008;31(4):53-4.